FIFRA

October 22, 2020
EPA Provides Expedited Pathway for Companies to Claim “Long-Lasting” Efficacy for Antiviral Products
September 29, 2020
OIRA Memorandum Directs Agencies to Consider Principles of Fairness in Administrative Enforcement and Adjudication
September 10, 2020
EPA’s OCSPP Reorganization Will Include New Risk Evaluation and Risk Management Divisions
August 26, 2020
EPA Announces Approval of First-Ever Long-Lasting Antiviral Product for Use against COVID-19
August 21, 2020
EPA Announces Proposal to Add Chitosan to the List of Active Ingredients Permitted in Exempted Minimum Risk Pesticide Products
July 30, 2020
EPA Announces the Approval of 13 Additional Products Effective against SARS-CoV-2
May 21, 2020
EPA Releases Proposed Rule Intended to Improve the Transparency of Guidance
May 15, 2020
Find B&C’s Updates And Analysis Of Chemical Regulatory Impacts Of COVID-19 In One Place
March 2, 2020
FIFRA Stakeholders:  How to Respond to an Enforcement Action or Inquiry
January 29, 2019
EPA Releases Year in Review, Highlighting Its Accomplishments and Environmental Progress
 1 2 3 >  Last › View 10 | 25 | 50 | 100 per page
 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-557-3800 • 202-557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy | Attorney Advertising | Trademarks
©2021 Bergeson & Campbell, P.C.
All Rights Reserved.

We are very pleased to offer complimentary subscription to our informative newsletter(s), but we will need to collect some information to do so.

Please carefully read the provisions of the PRIVACY POLICY and the TERMS OF SERVICE ( click to read )

When you opt-in by clicking the button below, you agree to share your USER ID, EMAIL ADDRESS, COMPANY AFFILIATION, and JOB TITLE for the purpose of receiving our emailed newsletter(s).

If you do not accept these terms of use, do not subscribe to our newsletter(s).




I agree to the collection and use of my personal data as described above.


I do not agree to the collection and use of my personal data as described above and therefore agree not to access this subscription form.